MK

Melanie A. Kleinschek

TI Theravance Biopharma R&D Ip: 10 patents #32 of 116Top 30%
📍 San Francisco, CA: #3,995 of 26,999 inventorsTop 15%
🗺 California: #55,401 of 386,348 inventorsTop 15%
Overall (All Time): #439,470 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
12410223 TNF-alpha variant fusion molecules Robin Allene Aglietti, Susannah D. BARBEE, Peter Bowers 2025-09-09
11878977 JAK inhibitors containing a 4-membered heterocyclic amide Paul R. Fatheree, Gary E. L. Brandt, Cameron Smith, Steven D. E. Sullivan, Lori Jean Van Orden +1 more 2024-01-23
11786517 Methods of treatment using a JAK inhibitor compound Glenn D. Crater 2023-10-17
11667637 Fused imidazo-piperidine JAK inhibitors Paul R. Fatheree, Gary E. L. Brandt, Cameron Smith, Steven D. E. Sullivan, Lori Jean Van Orden +1 more 2023-06-06
10550118 JAK inhibitors containing a 4-membered heterocyclic amide Paul R. Fatheree, Gary E. L. Brandt, Cameron Smith, Steven D. E. Sullivan, Lori Jean Van Orden +1 more 2020-02-04
10548886 Methods of treatment using a JAK inhibitor compound Glenn D. Crater 2020-02-04
10519153 Fused imidazo-piperidine JAK inhibitors Paul R. Fatheree, Gary E. L. Brandt, Cameron Smith, Steven D. E. Sullivan, Lori Jean Van Orden +1 more 2019-12-31
10406148 Methods of treatment using a JAK inhibitor compound Glenn D. Crater 2019-09-10
10392386 JAK inhibitors containing a 4-membered heterocyclic amide Paul R. Fatheree, Gary E. L. Brandt, Cameron Smith, Steven D. E. Sullivan, Lori Jean Van Orden +1 more 2019-08-27
10251874 Crystalline forms of a JAK inhibitor compound Marta Dabros, Venkat R. Thalladi, Jerry Nzerem, Glenn D. Crater 2019-04-09
10208040 Fused imidazo-piperidine JAK inhibitors Paul R. Fatheree, Gary E. L. Brandt, Cameron Smith, Steven D. E. Sullivan, Lori Jean Van Orden +1 more 2019-02-19